TOP-5 Price Targets of Analysts on 02/03/25
Reading Time: 2 minutes
DexCom [US2521311074]: Redburn Atlantic upgrades from "Neutral" to "Buy" and raises the price target from $85 to $115 (33% upside potential) The analyst highlights that DexCom is well-positioned to benefit from the structural growth of the continuous glucose monitoring (CGM) market. An annual revenue growth of 16% is expected by fiscal year 2027, particularly through expansion into the still underdeveloped segment of non-insulin-dependent Type 2 testing. Furthermore, expert confidence is bolstered by the upcoming next-generation G8 sensor. Redburn...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
